HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sufi M Thomas Selected Research

Sufi M Thomas Research Topics

Disease

34Neoplasms (Cancer)
01/2022 - 07/2003
24Squamous Cell Carcinoma of Head and Neck
01/2021 - 07/2003
12Head and Neck Neoplasms (Head and Neck Cancer)
06/2014 - 09/2004
5Carcinogenesis
12/2019 - 09/2004
2Neoplasm Metastasis (Metastasis)
01/2022 - 09/2005
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 09/2006
1Disease Progression
01/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Glioma (Gliomas)
01/2021
1Wounds and Injuries (Trauma)
01/2020
1Renal Cell Carcinoma (Grawitz Tumor)
01/2020
1Adenocarcinoma
12/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2019
1Fibrosis (Cirrhosis)
11/2015
1Cicatrix (Scar)
11/2015
1Inflammation (Inflammations)
11/2015
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
11/2015
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2013
1Carcinoma (Carcinomatosis)
01/2013
1Multiple Myeloma
12/2012
1Mouth Neoplasms (Oral Cancer)
07/2010
1Hypoxia (Hypoxemia)
11/2009

Drug/Important Bio-Agent (IBA)

22ErbB Receptors (EGF Receptor)IBA
06/2014 - 07/2003
8Cetuximab (Erbitux)FDA Link
02/2013 - 09/2006
7Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2009
7Erlotinib Hydrochloride (CP 358,774)FDA Link
06/2014 - 11/2009
4Phosphotransferases (Kinase)IBA
12/2019 - 09/2005
4Epidermal Growth Factor (EGF)IBA
01/2013 - 09/2004
4Biological ProductsIBA
11/2009 - 09/2006
4Gastrin-Releasing PeptideIBA
02/2009 - 09/2004
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2003
3Tyrosine Kinase InhibitorsIBA
11/2012 - 06/2009
3LigandsIBA
03/2007 - 09/2004
2ChemokinesIBA
01/2022 - 09/2005
2Mitogen-Activated Protein KinasesIBA
01/2022 - 04/2007
2CollagenIBA
11/2015 - 02/2015
2Sulindac (Copal)FDA LinkGeneric
06/2014 - 11/2012
2Biomarkers (Surrogate Marker)IBA
06/2014 - 11/2012
2ONX 0912IBA
12/2012 - 10/2012
2carfilzomibIBA
12/2012 - 10/2012
2OligonucleotidesIBA
08/2012 - 05/2009
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2012 - 05/2006
2guggulu extractIBA
02/2011 - 11/2009
2Cisplatin (Platino)FDA LinkGeneric
11/2009 - 09/2006
2saracatinibIBA
07/2008 - 07/2008
2src-Family KinasesIBA
07/2008 - 09/2004
2Bombesin Receptors (Bombesin Receptor)IBA
04/2007 - 09/2004
2Transforming Growth Factor alpha (TGF-alpha)IBA
10/2004 - 09/2004
1p38 Mitogen-Activated Protein KinasesIBA
01/2022
1Ion Channels (Ion Channel)IBA
01/2021
1A-Form DNA (A-DNA)IBA
10/2020
1Vasopressins (Vasopressin)IBA
01/2020
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
01/2020
1Complementary DNA (cDNA)IBA
01/2020
1TolvaptanFDA Link
01/2020
1Messenger RNA (mRNA)IBA
12/2019
1Calmodulin (Calcium-Dependent Activator Protein)IBA
12/2019
1Histone DemethylasesIBA
12/2019
1PhosphoproteinsIBA
03/2016
1NitrogenIBA
11/2015
1Oxygen (Dioxygen)IBA
11/2015
1CytokinesIBA
11/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2015
1Celecoxib (Celebrex)FDA Link
03/2013
1Pharmaceutical PreparationsIBA
03/2013
1EnzymesIBA
03/2013
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2013
1Peptide Nucleic AcidsIBA
02/2013
1NucleotidesIBA
02/2013
1Guanidine (Guanidine Nitrate)FDA Link
02/2013
1glutarylphenylalanine-4-nitroanilideIBA
02/2013
1ThymidineIBA
01/2013
1Proteasome InhibitorsIBA
12/2012
1Bortezomib (Velcade)FDA Link
12/2012
1Mechanistic Target of Rapamycin Complex 2IBA
11/2012
1Blood Proteins (Serum Proteins)IBA
11/2012
1TOR Serine-Threonine KinasesIBA
11/2012
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2012
1Mechanistic Target of Rapamycin Complex 1IBA
11/2012
1OSI 027IBA
11/2012
1Transcription Factors (Transcription Factor)IBA
08/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
06/2012
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
08/2011
14-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA
02/2011
1Annexin A5IBA
05/2010
1honokiolIBA
05/2010
1pregna-4,17-diene-3,16-dione (guggulsterone)IBA
11/2009
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
06/2009
1CrizotinibIBA
06/2009

Therapy/Procedure

10Therapeutics
01/2021 - 07/2003
2Radiotherapy
01/2022 - 11/2015
2Chemoprevention
03/2013 - 02/2011
1Drug Therapy (Chemotherapy)
01/2022
1Precision Medicine
01/2021
1Injections
12/2019
1Molecular Targeted Therapy
01/2013
1Neoadjuvant Therapy
11/2012
1Oral Administration
10/2012
1Intravenous Injections
08/2012